Inventiva (Euronext Paris and NASDAQ: IVA) announced the appointment of three senior executives as the biopharmaceutical company prepares for Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE